Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Tumor Ablation Therapy Device Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4626682
    • |
  • 10 September, 2025
    • |
  • Global
    • |
  • 125 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Tumor Ablation Therapy Device market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Tumor Ablation Therapy Device market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Tumor Ablation Therapy Device market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Tumor Ablation Therapy Device market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Tumor Ablation Therapy Device market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Tumor Ablation Therapy Device market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tumor Ablation Therapy Device
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Tumor Ablation Therapy Device market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Angiodynamics, AtriCure, Boston Scientific Corporation, BTG International, BVM Medical Limited, EDAP TMS S.A., Erbe Elektromedizin GmbH, Galil Medical, HealthTronics, INTIO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Tumor Ablation Therapy Device market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cryoablation
Radiofrequency Ablation
Market segment by Application
Hospital
Oncology Clinic
Others
Major players covered
Angiodynamics
AtriCure
Boston Scientific Corporation
BTG International
BVM Medical Limited
EDAP TMS S.A.
Erbe Elektromedizin GmbH
Galil Medical
HealthTronics
INTIO
Medtronic
Misonix
Neuwave Medical
Theraclion
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tumor Ablation Therapy Device product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tumor Ablation Therapy Device, with price, sales quantity, revenue, and global market share of Tumor Ablation Therapy Device from 2020 to 2025.
Chapter 3, the Tumor Ablation Therapy Device competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tumor Ablation Therapy Device breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Tumor Ablation Therapy Device market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tumor Ablation Therapy Device.
Chapter 14 and 15, to describe Tumor Ablation Therapy Device sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Tumor Ablation Therapy Device Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Cryoablation
    • 1.3.3 Radiofrequency Ablation
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Tumor Ablation Therapy Device Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Oncology Clinic
    • 1.4.4 Others
  • 1.5 Global Tumor Ablation Therapy Device Market Size & Forecast
    • 1.5.1 Global Tumor Ablation Therapy Device Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Tumor Ablation Therapy Device Sales Quantity (2020-2031)
    • 1.5.3 Global Tumor Ablation Therapy Device Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Angiodynamics
    • 2.1.1 Angiodynamics Details
    • 2.1.2 Angiodynamics Major Business
    • 2.1.3 Angiodynamics Tumor Ablation Therapy Device Product and Services
    • 2.1.4 Angiodynamics Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Angiodynamics Recent Developments/Updates
  • 2.2 AtriCure
    • 2.2.1 AtriCure Details
    • 2.2.2 AtriCure Major Business
    • 2.2.3 AtriCure Tumor Ablation Therapy Device Product and Services
    • 2.2.4 AtriCure Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 AtriCure Recent Developments/Updates
  • 2.3 Boston Scientific Corporation
    • 2.3.1 Boston Scientific Corporation Details
    • 2.3.2 Boston Scientific Corporation Major Business
    • 2.3.3 Boston Scientific Corporation Tumor Ablation Therapy Device Product and Services
    • 2.3.4 Boston Scientific Corporation Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Boston Scientific Corporation Recent Developments/Updates
  • 2.4 BTG International
    • 2.4.1 BTG International Details
    • 2.4.2 BTG International Major Business
    • 2.4.3 BTG International Tumor Ablation Therapy Device Product and Services
    • 2.4.4 BTG International Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 BTG International Recent Developments/Updates
  • 2.5 BVM Medical Limited
    • 2.5.1 BVM Medical Limited Details
    • 2.5.2 BVM Medical Limited Major Business
    • 2.5.3 BVM Medical Limited Tumor Ablation Therapy Device Product and Services
    • 2.5.4 BVM Medical Limited Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 BVM Medical Limited Recent Developments/Updates
  • 2.6 EDAP TMS S.A.
    • 2.6.1 EDAP TMS S.A. Details
    • 2.6.2 EDAP TMS S.A. Major Business
    • 2.6.3 EDAP TMS S.A. Tumor Ablation Therapy Device Product and Services
    • 2.6.4 EDAP TMS S.A. Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 EDAP TMS S.A. Recent Developments/Updates
  • 2.7 Erbe Elektromedizin GmbH
    • 2.7.1 Erbe Elektromedizin GmbH Details
    • 2.7.2 Erbe Elektromedizin GmbH Major Business
    • 2.7.3 Erbe Elektromedizin GmbH Tumor Ablation Therapy Device Product and Services
    • 2.7.4 Erbe Elektromedizin GmbH Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Erbe Elektromedizin GmbH Recent Developments/Updates
  • 2.8 Galil Medical
    • 2.8.1 Galil Medical Details
    • 2.8.2 Galil Medical Major Business
    • 2.8.3 Galil Medical Tumor Ablation Therapy Device Product and Services
    • 2.8.4 Galil Medical Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Galil Medical Recent Developments/Updates
  • 2.9 HealthTronics
    • 2.9.1 HealthTronics Details
    • 2.9.2 HealthTronics Major Business
    • 2.9.3 HealthTronics Tumor Ablation Therapy Device Product and Services
    • 2.9.4 HealthTronics Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 HealthTronics Recent Developments/Updates
  • 2.10 INTIO
    • 2.10.1 INTIO Details
    • 2.10.2 INTIO Major Business
    • 2.10.3 INTIO Tumor Ablation Therapy Device Product and Services
    • 2.10.4 INTIO Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 INTIO Recent Developments/Updates
  • 2.11 Medtronic
    • 2.11.1 Medtronic Details
    • 2.11.2 Medtronic Major Business
    • 2.11.3 Medtronic Tumor Ablation Therapy Device Product and Services
    • 2.11.4 Medtronic Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Medtronic Recent Developments/Updates
  • 2.12 Misonix
    • 2.12.1 Misonix Details
    • 2.12.2 Misonix Major Business
    • 2.12.3 Misonix Tumor Ablation Therapy Device Product and Services
    • 2.12.4 Misonix Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Misonix Recent Developments/Updates
  • 2.13 Neuwave Medical
    • 2.13.1 Neuwave Medical Details
    • 2.13.2 Neuwave Medical Major Business
    • 2.13.3 Neuwave Medical Tumor Ablation Therapy Device Product and Services
    • 2.13.4 Neuwave Medical Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Neuwave Medical Recent Developments/Updates
  • 2.14 Theraclion
    • 2.14.1 Theraclion Details
    • 2.14.2 Theraclion Major Business
    • 2.14.3 Theraclion Tumor Ablation Therapy Device Product and Services
    • 2.14.4 Theraclion Tumor Ablation Therapy Device Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Theraclion Recent Developments/Updates

3 Competitive Environment: Tumor Ablation Therapy Device by Manufacturer

  • 3.1 Global Tumor Ablation Therapy Device Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Tumor Ablation Therapy Device Revenue by Manufacturer (2020-2025)
  • 3.3 Global Tumor Ablation Therapy Device Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Tumor Ablation Therapy Device by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Tumor Ablation Therapy Device Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Tumor Ablation Therapy Device Manufacturer Market Share in 2024
  • 3.5 Tumor Ablation Therapy Device Market: Overall Company Footprint Analysis
    • 3.5.1 Tumor Ablation Therapy Device Market: Region Footprint
    • 3.5.2 Tumor Ablation Therapy Device Market: Company Product Type Footprint
    • 3.5.3 Tumor Ablation Therapy Device Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Tumor Ablation Therapy Device Market Size by Region
    • 4.1.1 Global Tumor Ablation Therapy Device Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Tumor Ablation Therapy Device Consumption Value by Region (2020-2031)
    • 4.1.3 Global Tumor Ablation Therapy Device Average Price by Region (2020-2031)
  • 4.2 North America Tumor Ablation Therapy Device Consumption Value (2020-2031)
  • 4.3 Europe Tumor Ablation Therapy Device Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Tumor Ablation Therapy Device Consumption Value (2020-2031)
  • 4.5 South America Tumor Ablation Therapy Device Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Tumor Ablation Therapy Device Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Tumor Ablation Therapy Device Sales Quantity by Type (2020-2031)
  • 5.2 Global Tumor Ablation Therapy Device Consumption Value by Type (2020-2031)
  • 5.3 Global Tumor Ablation Therapy Device Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Tumor Ablation Therapy Device Sales Quantity by Application (2020-2031)
  • 6.2 Global Tumor Ablation Therapy Device Consumption Value by Application (2020-2031)
  • 6.3 Global Tumor Ablation Therapy Device Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Tumor Ablation Therapy Device Sales Quantity by Type (2020-2031)
  • 7.2 North America Tumor Ablation Therapy Device Sales Quantity by Application (2020-2031)
  • 7.3 North America Tumor Ablation Therapy Device Market Size by Country
    • 7.3.1 North America Tumor Ablation Therapy Device Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Tumor Ablation Therapy Device Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Tumor Ablation Therapy Device Sales Quantity by Type (2020-2031)
  • 8.2 Europe Tumor Ablation Therapy Device Sales Quantity by Application (2020-2031)
  • 8.3 Europe Tumor Ablation Therapy Device Market Size by Country
    • 8.3.1 Europe Tumor Ablation Therapy Device Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Tumor Ablation Therapy Device Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Tumor Ablation Therapy Device Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Tumor Ablation Therapy Device Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Tumor Ablation Therapy Device Market Size by Region
    • 9.3.1 Asia-Pacific Tumor Ablation Therapy Device Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Tumor Ablation Therapy Device Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Tumor Ablation Therapy Device Sales Quantity by Type (2020-2031)
  • 10.2 South America Tumor Ablation Therapy Device Sales Quantity by Application (2020-2031)
  • 10.3 South America Tumor Ablation Therapy Device Market Size by Country
    • 10.3.1 South America Tumor Ablation Therapy Device Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Tumor Ablation Therapy Device Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Tumor Ablation Therapy Device Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Tumor Ablation Therapy Device Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Tumor Ablation Therapy Device Market Size by Country
    • 11.3.1 Middle East & Africa Tumor Ablation Therapy Device Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Tumor Ablation Therapy Device Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Tumor Ablation Therapy Device Market Drivers
  • 12.2 Tumor Ablation Therapy Device Market Restraints
  • 12.3 Tumor Ablation Therapy Device Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Tumor Ablation Therapy Device and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Tumor Ablation Therapy Device
  • 13.3 Tumor Ablation Therapy Device Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Tumor Ablation Therapy Device Typical Distributors
  • 14.3 Tumor Ablation Therapy Device Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Tumor Ablation Therapy Device. Industry analysis & Market Report on Tumor Ablation Therapy Device is a syndicated market report, published as Global Tumor Ablation Therapy Device Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Tumor Ablation Therapy Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo